• Linda Von Zeuner

I am pregnant. Should I get vaccinated against Covid-19?

Our vaccine rollout has started for the teachers and since plenty of teachers are younger women as well, the question has arisen whether it is safe to be vaccinated if you are pregnant, which is a concern I wholeheartedly understand.

Allow me to shed some light, and help you bear the burden of this decision. I am sure you have got enough on your mind!

Numerous vaccines are being, and have been evaluated for prevention of COVID-19, but pregnant and lactating women have been excluded from these trials for ethical reasons.

The vaccines currently in use (in South Africa) are either mRNA based (Pfizer) or Viral vector based (Johnson and Johnson).

Vaccines that are contraindicated in pregnancy are any live attenuated vaccine, for instance MMR, since they theoretically pose a risk of infection to the unborn fetus.

All of the vaccines (including those not currently available in South Africa) do not contain any form of a virus that REPLICATES, thus, they do not cause disease, but non specific side effects from activation of the immune system may occur.

Based on how mRNA and viral vector vaccines work, they are unlikely to pose a risk to pregnant women, the fetus or breastfeeding newborns, in fact, you will be providing antibodies to your babies so they are protected from COVID-19 as well.

Data from animal studies, vaccinated pregnant women and small prospective cohort studies have NOT shown harmful effects and have demonstrated a maternal immune response and transfer of maternal antibodies across the placenta and into breastmilk to confer passive immunity against SARS-COV-2 infections after maternal vaccination. Vaccine generated antibodies were present in umbilical cord blood and breastmilk samples.

All pregnant patients are advised to undergo vaccination, worldwide.

Patients who are at higher risk of exposure to SARS-COV-2 or at highest risk of having severe disease (patients with diabetes, obesity or hypertension) may benefit most.

Pregnancy itself is associated with an increased risk of severe infection, but some patients may elect to defer vaccination weighing their personal risk of COVID-19 exposure and disease severity against the limited but increasingly data regarding the safety and efficacy of COVID-19 vaccines during pregnancy.


  1. Evidence suggests that pregnancy does not increase susceptibility to SARS-COV-2 infection but it does appear to worsen the clinical course of COVID-19 compared to non pregnant females of the same age.

  2. Most infected pregnant women (over 90%) recover without undergoing hospitalisation, rapid deterioration can occur and symptomatic pregnant patients appear to be at an increased risk of severe disease and death compared to symptomatic non-pregnant females of similar age.

  3. Risk factors for severe disease and death in pregnancy include older mean age (35 and older), obesity, and pre-existing medical comorbidities, especially hypertension and diabetes.

  4. The risk of miscarriage does not appear to be increased, but data on first and second trimester infections are limited.

  5. Preterm and caesarian delivery have been increased in most studies and the increased risk appears to be limited to patients with severe or critical disease.

  6. No increased risk of congenital anomalies has been reported.

  7. Risk of stillbirth in pregnant mothers with SARA-COV-2 infection are still the same as the general population.

  8. Over 95% of newborns of SARS-COV-2 positive mothers have been in good condition at birth. Most are asymptomatic, some develop symptoms of mild infection. Neonatal morbidity (requiring ICU/ ventilation) have largely been attributed to preterm birth and critical maternal COVID-19.

  9. An analysis of 12 countries with pregnant patients with confirmed or suspected SARS-COV-2 reported all cause early neonatal death rates of (0.2-0.3%), which were no higher than pre-COVID data. These numbers are not South African statistics but are significant nonetheless.


  • Do not receive your vaccine in 14 days of receiving another vaccine such as Tetanus or Influenza.

  • If you become pregnant after receiving a first dose of Pfizer, you can still get the second dose at the same time than you would if you had not been pregnant.

  • Anti-D immunoglobulin (what you get after birth if you and your baby's blood group is not compatible) doesn't interfere with the immune response of the vaccine.

  • If you experience any immune response symptoms, Paracetamol is safe to use.

On a last note...

This virus has stolen so much from us, no single person has been through this unscathed, no matter in what walk of life or social circumstance you find yourself in.

If you have been planning a family, there is no reason to postpone it due to COVID-19 risk. Pregnancy related risks have not been well established, but the evidence suggests that the risks are not high enough to postpone a wanted pregnancy.


  1. Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1641.

  2. Lokken EM, Taylor GG, Huebner EM, et al. Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients. Am J Obstet Gynecol 2021.

  3. Ellington S, Strid P, Tong VT, et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:769.

  4. Bunyavanich S, Grant C, Vicencio A. Racial/Ethnic Variation in Nasal Gene Expression of Transmembrane Serine Protease 2 (TMPRSS2). JAMA 2020; 324:1567.

  5. www.ACOG.org (Accessed on September 16, 2020).

  6. Male V. Are COVID-19 vaccines safe in pregnancy? Nat Rev Immunol 2021; 21:200.

  7. FDA. Emergency Use Authorization (EUA) . Pfizer-BioNTech COVID-19 Vaccine/ BNT162b2 https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine (Accessed on February 25, 2021).

  8. Emergency Use Authorization (EUA). Moderna COVID-19 Vaccine/mRNA-1273 https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine (Accessed on February 25, 2021).

  9. CDC National Center for Immunization & Respiratory Diseases. COVID 19 vaccine safety update. Advisory Committee on Immunization Practices (ACIP) March 1, 2021 https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-02/28-03-01/05-covid-Shimabukuro.pdf (Accessed on March 02, 2021).

  10. Oliver SE, Gargano JW, Scobie H, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. MMWR Morb Mortal Wkly Rep 2021; 70:329.

  11. Janssen COVID-19 Vaccine https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine (Accessed on March 01, 2021).

  12. Gray KJ, Bordt EA, Atyeo C, et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. medRxiv 2021.

  13. Mithal LB, Otero S, Shanes ED, et al. Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy. Am J Obstet Gynecol 2021.

  14. Rottenstreich A, Zarbiv G, Oiknine-Djian E, et al. Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination. Clin Infect Dis 2021.

  15. Perl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women. JAMA 2021; 325:2013.

  16. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med 2021; 384:2273.

  17. Prabhu M, Murphy EA, Sukhu AC, et al. Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood. Obstet Gynecol 2021.

  18. Beharier O, Plitman Mayo R, Raz T, et al. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J Clin Invest 2021.

  19. Collier AY, McMahan K, Yu J, et al. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and LactatingWomen. JAMA 2021.

  20. CDC. V-safe Pregnancy Registry. April 20, 2021 https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafepregnancyregistry.html (Accessed on April 26, 2021).

  21. Rasmussen SA, Lyerly AD, Jamieson DJ. Delaying Pregnancy during a Public Health Crisis - Examining Public Health Recommendations for Covid-19 and Beyond. N Engl J Med 2020; 383:2097.

  22. American College of Obstetricians and Gynecologists. Practice advisory: Vaccinating pregnant and lactating patients against COVID-19 https://www.acog.org/en/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-Pregnant-and-Lactating-Patients-Against-COVID-19 (Accessed on February 08, 2021).

  23. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370:m3320.

  24. Yanes-Lane M, Winters N, Fregonese F, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis. PLoS One 2020; 15:e0241536.

  25. Oshay RR, Chen MYC, Fields BKK, et al. COVID-19 in pregnancy: a systematic review of chest CT findings and associated clinical features in 427 patients. Clin Imaging 2021; 75:75.

  26. NIH COVID-19 Treatment Guidelines https://covid19treatmentguidelines.nih.gov/overview/management-of-covid-19/ (Accessed on April 22, 2020).

  27. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323:1239.

  28. Badr DA, Mattern J, Carlin A, et al. Are clinical outcomes worse for pregnant women at ≥20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol 2020; 223:764.

  29. Metz TD, Clifton RG, Hughes BL, et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol 2021; 137:571.

  30. Qeadan F, Mensah NA, Tingey B, Stanford JB. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC Pregnancy Childbirth 2021; 21:305.

  31. DeBolt CA, Bianco A, Limaye MA, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol 2021; 224:510.e1.

  32. Lokken EM, Taylor GG, Huebner EM, et al. Higher SARS-CoV-2 Infection Rate in 1 Pregnant Patients. Am J Obstet Gynecol 2021.

  33. Pineles BL, Goodman KE, Pineles L, et al. In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19. Ann Intern Med 2021.

  34. Karimi L, Makvandi S, Vahedian-Azimi A, et al. Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis. J Pregnancy 2021; 2021:8870129.

  35. Galang RR, Newton SM, Woodworth KR, et al. Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021. Clin Infect Dis 2021.

  36. Mullins E, Hudak ML, Banerjee J, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol 2021; 57:573.

  37. Huntley BJF, Mulder IA, Di Mascio D, et al. Adverse Pregnancy Outcomes Among Individuals With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review and Meta-analysis. Obstet Gynecol 2021; 137:585.

  38. Jering KS, Claggett BL, Cunningham JW, et al. Clinical Characteristics and Outcomes of HospitalizedWomen Giving Birth With andWithout COVID-19. JAMA Intern Med 2021; :e1.

  39. Martinez-Portilla RJ, Sotiriadis A, Chatzakis C, et al. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx). Ultrasound Obstet Gynecol 2021; 57:224.

880 views0 comments

Recent Posts

See All